79
63
Growth Score 79 in past quarter
-8 pts
Heat Score 63 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
308384
Creasallis develops biotechnology solutions, including CreaTap, to improve antibody drug penetration into tumors.
- Zahra Jawad: CEO and Founder
About the Company
Creasallis specializes in biotechnology, focusing on the development of innovative antibody engineering solutions. The company's flagship technology, CreaTap, enhances the penetration of antibody-based drugs into tumors, potentially increasing their efficacy. Creasallis leverages its expertise in structural and molecular biology to create more
effective therapeutic solutions. The company has also been recognized in startup competitions, winning awards such as 50 EVOLVE Pipettes and accessories to support its research efforts.